Table 2.
Prevalence of both TYR p.(Ser192Tyr)/S192Y and p.(Arg402Gln)/R402Q variants in OCA cohorts.
OCA cohorts with missing heritability (individuals with only 1 TYR pathogenic or likely pathogenic variant identified) | Molecularly diagnosed OCA1 cohorts (individuals with 2 TYR pathogenic or likely pathogenic variant identified) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
This studya | Hutton & Spritz8 | Hutton & Spritz15 | Oetting17 | Ghodsinejad Kalahroudi20 | Lasseaux22 | Gronskov31 | Campbell30 | Hutton & Spritz15 | Oetting17 | Ghodsinejad Kalahroudi20 | Gronskov31 | |
Phenotype | Nystagmus and/or albinism | AROA/ mild OCA | OCA | OCA1 | OCA1 | Nystagmus and/or absence of fovea | Albinism (OCA, AROA or OA) | Nystagmus and at least one other ocular feature of albinism, no skin hypopigmentation | OCA | OCA1 | OCA1 | Albinism (OCA, AROA or OA) |
Country (ethnicity) | England | (Caucasian) | USA, Canada, Northern Europe (non-Hispanic/ Latino Caucasians) | NA | (Iranian) | France | Scandinavia (Scandinavian) | England | USA, Canada, Northern Europe (non-Hispanic/ Latino Caucasians) | NA | (Iranian) | Scandinavia (Scandinavian) |
No of the individuals in the cohort | 51 | 20 | 13 | 3 | 6 | 158 | 29 | 4 | 71 | 9 | 19 | 2 |
No of individuals hom or het for both TYR S192Y & R402Q | 49 | 1 | 3 | 2 | 0 | 64 | 21 | 4 | 2 | 0 | 0 | 0 |
Proportion of study cohort where S192Y/R402Q haplotype is possible | 49/51 (96.1%) | 1/20 (5%) | 3/13 (23.1%) | 2/3 (66.7%) | 0/6 (0%) | 64/158 (40.5%) | 21/29 (72.4%) | 4/4 (100%) | 2/71 (2.8%) | 0/9 (0%) | 0/19 (0%) | 0/2 (0%) |
Combined proportion where S192Y/R402Q haplotype is possible | 144/284 (50.7%) | 2/101 (2.0%) |
AROA autosomal recessive ocular albinism, AXD in-house Amish exome database, het heterozygous, hom homozygous, OCA oculocutaneous albinism, OA ocular albinism, no number.
aThis cohort includes individuals previously reported in Norman et al. and O’Gorman et al.